Latigo Biotherapeutics, Inc. Common Stock (LTGO) is a publicly traded the market company. As of November 3, 2026, LTGO trades at $14.55 with a market cap of $895.70M and a P/E ratio of 0.00. LTGO moved +8.29% today. Year to date, LTGO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $13.32 to $25.93. Analyst consensus is strong buy with an average price target of $57.67. Rallies surfaces LTGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Latigo Biotherapeutics, Inc. Common Stock (LTGO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LTGO moved +8.29% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $14.55 |
| Market Cap | $895.70M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.93 |
| 52-Week Low | $13.32 |
| Volume | 185.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover LTGO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $57.67.